Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo
Dahae Lee, Hyejung Jo, Yoojin Jang, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 678-678
Open Access | Times Cited: 13

Showing 13 citing articles:

BANNMDA: a computational model for predicting potential microbe–drug associations based on bilinear attention networks and nuclear norm minimization
Mingmin Liang, Xianzhi Liu, Juncai Li, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Updates on Drug Designing Approach Through Computational Strategies: a Review
Iqbal Azad, Tahmeena Khan, Naseem Ahmad, et al.
Future Science OA (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 16
Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
Clara Appiah, Shitian Chen, Afia Ibnat Pori, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 9
Alloferon-1 ameliorates estrogen deficiency-induced osteoporosis through dampening the NLRP3/caspase-1/IL-1β/IL-18 signaling pathway
Shuai Qiao, Xiangrui Zhang, Ziyi Chen, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110954-110954
Closed Access | Times Cited: 7
Identification of Hub Genes and Prediction of Targeted Drugs for Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis
Ting Cui, Zhican Huang, Kun Luo, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Brief overview of edible insects: exploring consumption and promising sustainable uses in Latin America
Carlos Granados-Echegoyen, Alfonso Vásquez‐López, Nancy Calderón-Cortés, et al.
Frontiers in Sustainable Food Systems (2024) Vol. 8
Open Access | Times Cited: 1
Aging-related genes related to the prognosis and the immune microenvironment of acute myeloid leukemia
Dongxu Gang, Yinyan Jiang, Xiaofang Wang, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 10, pp. 2991-3005
Closed Access | Times Cited: 4
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 2
Effects of alloferon and its analogues on reproduction and development of the Tenebrio molitor beetle
Karolina Walkowiak‐Nowicka, Szymon Chowański, Joanna Pacholska‐Bogalska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Therapeutic effect of targeted antioxidant natural products
Sohini Mukherjee, Hitesh Chopra, Rajat Goyal, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access
A proteomics perspective on 2 years of high-intensity training in horses: a pilot study
Lisa Johansson, Sara Ringmark, J. Bergquist, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Influenza B Virus: Target and acting mechanism of antiviral drugs
Jicheng Han, Chunhui Yang, Yan Xiao, et al.
Microbial Pathogenesis (2024) Vol. 197, pp. 107051-107051
Closed Access
Page 1

Scroll to top